von Herrath M G, Efrat S, Oldstone M B, Horwitz M S
Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9808-13. doi: 10.1073/pnas.94.18.9808.
The adenovirus (Ad) genome contains immunoregulatory and cytokine inhibitory genes that are presumed to function in facilitating acute infection or in establishing persistence in vivo. Some of these genes are clustered in early region 3 (E3), which contains a 19-kDa glycoprotein (gp19) that inhibits the transport of selected class I major histocompatibility complex (MHC) molecules out of the endoplasmic reticulum. In addition, the E3 region contains three protein inhibitors of the cytolytic function of tumor necrosis factor alpha (TNF-alpha). Because type I autoimmune diabetes destroys islets by mechanisms that involve class I MHC and TNF-alpha, we investigated whether the entire cassette of Ad E3 genes might prevent the onset of diabetes in a well studied lymphocytic choriomeningitis viral (LCMV) murine model of virus-induced autoimmune diabetes. In this model, a LCMV polypeptide (either glycoprotein or nucleoprotein) expressed as a transgene in the islets is a target for autoimmune destruction of beta cells after LCMV infection. In this scenario the LCMV-induced immune response is directed not only against the virus but also against the LCMV transgenes expressed in the beta cells. Our experiments demonstrated a very efficient prevention of this LCMV-triggered diabetes by the Ad E3 genes. This resulted from the inhibition of target cell recognition by a fully competent and LCMV-primed immune system. Unlike the results from the beta-2 microglobulin gene deletion experiments, our approach shows that selective regulation at the level of the target cell is sufficient to prevent autoimmune diabetes without disrupting the function of the systemic immune response. Although the Ad genes in these experiments were provided as transgenes, recent experiments may permit the introduction of such genes through the use of viral vectors. Although the decrease in class I MHC in islets by Ad genes was demonstrated in these in vivo studies, the relative importance of this process and the control of TNF-alpha cytolysis must await further genetic dissection of the introduced Ad genes.
腺病毒(Ad)基因组包含免疫调节和细胞因子抑制基因,推测这些基因在促进急性感染或在体内建立持续性感染中发挥作用。其中一些基因聚集在早期区域3(E3),该区域含有一种19 kDa的糖蛋白(gp19),它能抑制特定的I类主要组织相容性复合体(MHC)分子从内质网中转运出来。此外,E3区域还包含三种肿瘤坏死因子α(TNF-α)细胞溶解功能的蛋白抑制剂。由于I型自身免疫性糖尿病通过涉及I类MHC和TNF-α的机制破坏胰岛,我们研究了Ad E3基因的整个基因盒是否能在一个经过充分研究的淋巴细胞性脉络丛脑膜炎病毒(LCMV)诱导的自身免疫性糖尿病小鼠模型中预防糖尿病的发生。在这个模型中,在胰岛中作为转基因表达的LCMV多肽(糖蛋白或核蛋白)是LCMV感染后β细胞自身免疫破坏的靶点。在这种情况下,LCMV诱导的免疫反应不仅针对病毒,还针对在β细胞中表达的LCMV转基因。我们的实验证明,Ad E3基因能非常有效地预防这种LCMV引发的糖尿病。这是由于一个完全有功能且经LCMV致敏的免疫系统对靶细胞识别的抑制。与β2微球蛋白基因缺失实验的结果不同,我们的方法表明,在靶细胞水平上的选择性调节足以预防自身免疫性糖尿病,而不会破坏全身免疫反应的功能。尽管在这些实验中Ad基因是作为转基因提供的,但最近的实验可能允许通过使用病毒载体来引入此类基因。虽然在这些体内研究中证明了Ad基因可使胰岛中的I类MHC减少,但这一过程的相对重要性以及对TNF-α细胞溶解的控制必须等待对引入的Ad基因进行进一步的基因剖析。